Imig, John D <br/><br/>
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Oct 2005 
 - 975-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/01.HYP.0000176237.74820.75  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Albuminuria--physiopathology<br/>Angiotensins<br/>Animals<br/>Blood Pressure--drug effects<br/>Cell Count<br/>Epoxide Hydrolases--antagonists & inhibitors<br/>Hypertension--chemically induced<br/>Kidney--pathology<br/>Kidney Diseases--prevention & control<br/>Lauric Acids--pharmacology<br/>Macrophages--pathology<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sodium Chloride